Article

UN Competition Policy Meeting to Discuss Big Pharma 'Tactics'

October 14, 2016

Potentially anticompetitive practices in the pharmaceutical industry are among topics to be discussed at a global meeting on competition next week in Geneva, Switzerland.     Referring to agreements which occur when a patent holder compensates a competitor to delay or abandon the launch of a generic drug, United Nations Conference on Trade and Development (UNCTAD) economist Ebru Gokce commented: "We're not questioning the merit of patent protection. We're questioning the anti-competitive nature of practices, such as pay-for-delay agreements, that prolong market exclusivity."   The 15th Intergovernmental Group of Experts Meeting on Competition Law and Policy takes place from October 19 to 21.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Related Videos
Gen Li
Gen Li
Ted Sweetser
Ted Sweetser
Ted Sweetser
Related Content